Eli Lilly & Co: (NYSE: LLY)
$54.53
-0.39 (-0.71%)
Volume 2,214,943
May 23 01:49 PM ET
Zacks Rank: 3-Hold 
| #3 |
Financial Overview
P/E
| PE (forward) | 14.04 |
| Trailing 12 Months | 15.21 |
| PEG Ratio | -63.82 |
Price Ratios
| Price/Book | 4.15 |
| Price/Cash Flow | 12.14 |
| Price / Sales | 2.74 |
Current Ratio
| 03-31-13 | 1.62 |
| 12-31-12 | 1.55 |
| 09-30-12 | 2.02 |
Net Margin
| 03-31-13 | 20.45 |
| 12-31-12 | 18.08 |
| 09-30-12 | 18.15 |
Inventory Turnover
| 03-31-13 | 1.88 |
| 12-31-12 | 1.93 |
| 09-30-12 | 2.03 |
EPS Growth
| vs. Previous Year | 23.91 |
| vs. Previous Quarter | 34.12 |
ROE
| 03-31-13 | 26.64 |
| 12-31-12 | 25.26 |
| 09-30-12 | 25.95 |
Quick Ratio
| 03-31-13 | 1.28 |
| 12-31-12 | 1.24 |
| 09-30-12 | 1.65 |
Pre-Tax Margin
| 03-31-13 | 26.65 |
| 12-31-12 | 23.93 |
| 09-30-12 | 23.96 |
Debt-to-Equity
| 03-31-13 | 0.30 |
| 12-31-12 | 0.37 |
| 09-30-12 | 0.34 |
Sales Growth
| vs. Previous Year | 0.00 |
| vs. Previous Quarter | -5.96 |
ROA
| 03-31-13 | 12.05 |
| 12-31-12 | 11.41 |
| 09-30-12 | 11.54 |
Operating Margin
| 03-31-13 | 17.71 |
| 12-31-12 | 16.75 |
| 09-30-12 | 16.79 |
Book Value
| 03-31-13 | 13.24 |
| 12-31-12 | 12.73 |
| 09-30-12 | 13.84 |
Debt to Capital
| 03-31-13 | 22.86 |
| 12-31-12 | 27.20 |
| 09-30-12 | 25.55 |
